Module 4: Osteosarcoma and Condrosarcoma
Available from February 2027
Module 4: Osteosarcoma and Condrosarcoma
Available from February 2027
08/02/2027
Osteosarcoma: state of the art in the new WHO classification
08/02/2027
Benign and malignant chondroid tumors
08/02/2027
Surgical treatment of osteosarcoma
08/02/2027
Surgical treatment of cartilage tumors
08/02/2027
Chemotherapy in the treatement of osteosarcoma
08/02/2027
Chemotherapy and IDH1 target in chondrosarcoma
08/02/2027
Phase I trial in osteosarcoma and chondrosarcoma: the MDACC experience
08/02/2027
DR5 in chondrosarcoma: from clinical trial to approval path
08/02/2027
Drug development in osteosarcoma and chondrosarcoma: the Chinese perspective
08/02/2027
Stereotatic Radiotherapy for lung metastasese in chodrosarcoma and osteosarocma
08/02/2027
Genomic landscape and clinical application for osteosarcoma: the COG experience
08/02/2027
Dedifferentiated chodrosarcoma: chemotherapy and immunecheckpoint inhibitors
08/02/2027
Osteosarcoma TME: state of the art
08/02/2027
Lung metastasectomy do and don'ts: osteosarcoma and chondrosarcoma
08/02/2027
Clinical case discussion (live online session)
Module director: Palmerini Emanuela, IT/USA
